abstract |
The present invention relates to an amorphous torasemide modification, to a process for the preparation thereof, to its use as a raw material for the preparation of pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing this amorphous torasemide modification as well as to its use as a diuretic. |